Ravuconazole is a potent antifungal drug used to treat various fungal infections. However, during its manufacturing, some impurities may be formed. These impurities can affect the quality and safety of the drug, and thus their identification and quantification is essential. The most common impurities found in Ravuconazole include related substances, degradation products, and residual solvents. Strict regulatory guidelines require manufacturers to monitor and control these impurities to ensure the drug's efficacy and safety.
